Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$20.01
▼ $0.18 (-0.9%)
Market data updated: 09/20 12:15 PM
News analyzed: 09/20/2026
Market Cap
Not available
Day Range
$19.76 - $20.25
52-Week Range
$14.80 - $23.13
Beta
—
Next Earnings
—
Support
$15.40
Resistance
$20.75
-0.5% (1Y)
🟡 Moderate
Strengths: 11/15 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟢 Bullish
Technical Trend
🟢 Bullish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Golden Cross
SMA 50 recently crossed above SMA 200
Technical
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: -0.13 (3y annualized return -7.6% / max drawdown 58.7%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
XP Inc. (XP) demonstrates a robust overall investor score of 82, driven primarily by a near-perfect news category score of 100, reflecting a strong narrative of progress and analyst optimism. The company’s recent updates—including federal approvals for water extraction, Indigenous community partnerships, and construction financing milestones—align with positive analyst upgrades (e.g., Itau BBA’s ‘Outperform’ rating with a $22 price target) and earnings highlights emphasizing record client assets and strategic resilience. Technically, XP’s strength is evident in its price holding above both the 50-day and 200-day moving averages, alongside a positive MACD histogram indicating upward momentum and an ADX of 33.5, signaling a strong trend. However, the stock’s RSI (77.2) and %K (82.9) readings suggest it is nearing overbought territory, which could signal potential short-term volatility or a pullback. Meanwhile, the risk category’s lower score (42) is heavily influenced by the **Kalmár indicator**, which reveals a 3-year annualized return of -8.0% and a maximum drawdown of 58.7%, underscoring historical volatility and downside risk despite recent gains (+26.2% over the past 3 months relative to the benchmark).
XP’s price remains above both the 50-day and 200-day moving averages, with a positive MACD histogram and strong ADX (33.5) indicating a clear upward trend. However, the RSI (77.2) and %K (82.9) are in overbought territory, signaling potential overvaluation or imminent pullback pressure.
While the bullish trend is confirmed, overbought conditions may prompt traders to take profits or reduce exposure, potentially leading to short-term volatility.
The news category is overwhelmingly positive, with multiple updates on project milestones, analyst upgrades (e.g., Itau BBA’s ‘Outperform’ rating), and earnings highlights emphasizing record client assets and strategic resilience.
Positive news drives investor sentiment and institutional confidence, often leading to sustained upward price action and reduced perceived risk.
The **Kalmár indicator** shows a 3-year annualized return of -8.0% and a maximum drawdown of 58.7%, while the ATR (3.6% of price) suggests moderate volatility. These metrics highlight historical downside risk despite recent gains.
The high drawdown and negative long-term performance underscore potential long-term volatility and the need for caution, even amid short-term bullish signals.
StockIQ conclusion
XP Inc. exhibits a balanced profile with a strong technical foundation and overwhelmingly positive news sentiment, supported by recent outperformance and institutional upgrades. However, the stock’s overbought conditions and historical volatility—highlighted by the **Kalmár indicator**—introduce near-term risks that could temper upside potential. The working strengths suggest resilience and momentum, while concerns around overvaluation and drawdown risk necessitate cautious positioning. Investors should monitor the interplay between technical indicators and news developments to assess the stock’s trajectory.
Written automatically from the computed data shown on this page only — not investment advice.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
91
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
today · $20.01
Evidence: 11 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
today · $20.01
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
1d ago · $20.01
Evidence: 11 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
1d ago · $20.12
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
2d ago · $20.19
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
2d ago · $20.19
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
3d ago · $19.76
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
3d ago · $19.76
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
4d ago · $19.53
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
4d ago · $19.53
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
4d ago · $19.40
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
5d ago · $19.53
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
6d ago · $19.86
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
7d ago · $19.86
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
9d ago · $20.06
Evidence: 1.5x recent average volume
What happened after
Still awaiting outcome
10d ago · $19.04
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
10d ago · $19.04
Evidence: 9 bullish / 1 bearish technical signals agreeing
What happened after
10d ago · $19.20
Evidence: 1.5x recent average volume
What happened after
11d ago · $19.99
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
11d ago · $19.99
Evidence: 9 bullish / 2 bearish technical signals agreeing
What happened after
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🕰️ StockIQ Time Machine
What did StockIQ know — and when? Pick a date from the real accumulated history.
As of September 1, 2026
Then
81
$18.23
Now
91
$20.01
What happened since
Signals detected by this date
No signals detected by this date
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
No data available
Quality
No data available
Value
No data available
Momentum
97
Risk
42
Sentiment
100
Fundamental
No data available
Institutional
100
Stocks with a similar DNA right now
🕵️ What the Detective found on XP
Detective Score 70/100 · 2 signals convergingOverall, the signals found here lean positive.
🧠 What the Detective thinks
2 signals are currently converging on XP at once — see each one broken down below, in plain language, with its own positive/negative read.
What this means now: Several different technical indicators are currently agreeing on the same direction at once — that's unusual; most days they contradict each other.
Why it matters: When several technical indicators agree at once, that's usually more reliable than any single indicator alone.
What this means now: The price has formed a distinct technical structure (a trading range, shakeout, or breakout) that the Wyckoff method treats as a key moment where big money is building or unwinding a position.
Why it matters: May provide an additional indication of trading structure, but is not proof of future direction.
📊 Historically, this signal type
This is not a prediction and not investment advice — just a plain-language read of real, already-computed signals. Full details: Stock Detective →
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of XP Inc. has centered on its strong financial performance and bullish analyst sentiment. The company reported record client assets and an 8% revenue growth to BRL5.1 billion in Q2 2026, with its corporate segment surging 117% and return on equity rising to 22.5%. Analysts, including Itau BBA and others, upgraded XP’s stock rating and price targets, projecting a potential 39.2% upside, while some suggest the stock may be undervalued by up to 34%. The focus also includes XP’s strategic resilience amid market challenges and its expanding ambitions in the U.S. banking sector.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about XP Inc.. News trend score: 100. Reason: 13 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
33
🎯 Conviction (vs. Emotion)
50
Psychology
37
Fundamentals
—
Technical
97
Valuation
—
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price (3M)
+31%
Market Narrative
72
Fundamental Reality
50
Narrative Gap
+22
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior here is dominated by **FOMO**, with euphoric overconfidence in the rally’s continuation. The extreme RSI (78), Bollinger %B (0.91), and sentiment (100/100) signal a detached, momentum-driven mindset—traders may be chasing gains without regard to valuation. The narrative gap (38) further suggests a disconnect between reality (50) and optimism (88), raising the open question: *Will traders sustain participation despite overbought conditions?* The key tension lies between euphoria’s persistence and anchoring near resistance, which could trigger re-evaluation if momentum stalls.
Updated: 09/09/2026, 09:42 AM
What could change this?
👥 What the crowd believes
"Itau BBA analyst upgrades XP to Outperform with a $22 price target"
"XP Inc reports 8% revenue growth to BRL5.1 billion, with corporate segment surging 117%"
"XP (XP) Stock May Be 34% Undervalued Following Strong Q2 Earnings"
"Will XP’s (XP) Solid Q2 and U.S. Banking Ambition Shift Its Core Investment Narrative?"
🧠 Market Brain events driving this
📈 19D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Thorstein Veblen — 80/100
🔴 Weakest match
Morgan Housel — 14/100
🗣️ Why do they disagree?
Based on their documented principles, the model estimates that Veblen’s growth‑value focus yields a relatively high score (80) while Smith’s perfect score reflects a lack of dividend or growth data rather than a positive assessment. Livermore’s moderate score (68) and the many 50‑point entries from Graham, Fisher, Lynch, Bagehot and Graham‑Enterprising all signal that these investors could not form a definitive opinion because essential balance‑sheet, valuation or fundamentals data were missing. The mid‑range scores (43‑42) from the efficient‑market view, Mackay, Marks‑cycle and Schwager highlight concerns about weak evidence, possible crowd delusion, and a neutral market‑cycle position, whereas Marks (37) and Loeb (36) flag risk and valuation cautions. Finally, the lowest scores from Nelson and Housel (both 14) underscore their view of an over‑stretched, volatile environment that would likely deter patient holders.
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 80
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟢 69
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 50
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 46
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 45
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 43
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 42
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 37
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 36
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 20
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 14
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Based on the last 282 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (11 bullish · 1 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 10.6.2026 | $0.200 |
| 9.6.2026 | $0.200 |
| 10.12.2025 | $0.180 |
| 9.12.2025 | $0.180 |
| 10.12.2024 | $0.650 |
| 9.12.2024 | $0.650 |
| 12.12.2023 | $0.730 |
| 11.12.2023 | $0.730 |
| 11.9.2023 | $0.580 |
| 10.9.2023 | $0.580 |
Sentiment based on basic keywords (not AI) — 13 positive, 4 neutral, 3 negative out of the last 20 articles.
Yahoo · 18.9.2026
Benzinga · 18.9.2026
Benzinga · 18.9.2026
Yahoo · 17.9.2026
Benzinga · 9.9.2026
Benzinga · 2.9.2026
Benzinga · 31.8.2026
Benzinga · 31.8.2026
Yahoo · 25.8.2026
GuruFocus.com · 25.8.2026
Yahoo · 24.8.2026
Zacks · 24.8.2026
Simply Wall St. · 21.8.2026
Simply Wall St. · 21.8.2026
Simply Wall St. · 21.8.2026
Insider Monkey · 20.8.2026
Zacks · 19.8.2026
Zacks · 19.8.2026
SeekingAlpha · 18.8.2026
MarketBeat · 17.8.2026
StockIQ doesn't currently have enough real data to compute a reliable score for XP Inc. (XP) — only 3 of 7 categories are available right now. Rather than show a misleading number, this page shows which data is missing instead.
StockIQ doesn't give buy/sell recommendations — and for XP specifically, there currently isn't enough real data (only 3 of 7 categories available) to state even a factual score reliably. Check back once more data is available.
XP's technical score is 97/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: SMA 50 recently crossed above SMA 200; Price is above the 50-day average; Price is above the 200-day average.
Based on the real signals StockIQ computed: Calmar: -0.13 (3y annualized return -7.6% / max drawdown 58.7%); Volume is falling despite the price advance — possible weakening.
Yes — XP has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 4 purchases and 0 sales out of the last 5 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| XPAC Sponsor LLC | Other Transaction | 19.8.2021 | 259,717 | -259,717 | — |
| XP Inc. | Open Market Purchase | 3.8.2021 | 38,900 | +38,900 | — |
| XP Inc. | Open Market Purchase | 3.8.2021 | 1,222,500 | +1,222,500 | — |
| XP Inc. | Open Market Purchase | 3.8.2021 | 500,000 | +500,000 | — |
| XP Inc. | Open Market Purchase | 3.8.2021 | 461,100 | +461,100 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
19,222,230 shares short as of 2026-08-31 · vs. 19,619,983 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
48.6% of trading volume this week was short selling, vs. 27.7% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology